Cirrhotic liver: What's that nodule? The LI-RADS approach
- PMID: 25996905
- DOI: 10.1002/jmri.24937
Cirrhotic liver: What's that nodule? The LI-RADS approach
Abstract
The Liver Imaging Reporting and Data System (LI-RADS) is an American College of Radiology (ACR)-endorsed diagnostic system of standardized terminology, interpretation, and reporting for imaging examinations of the liver in patients at high risk for hepatocellular carcinoma (HCC). LI-RADS assigns a category to observations in the liver indicating the likelihood of benignity or HCC. LI-RADS categories include LR-1: Definitely Benign, LR-2: Probably Benign, LR-3: Intermediate Probability for HCC, LR-4: Probably HCC, LR-5: Definite HCC, LR-5V: Definite HCC with Tumor in Vein, LR-Treated: Treated HCC, LR-M Probable Malignancy, not specific for HCC. This article reviews the types of nodules seen in the cirrhotic liver, examines core LI-RADS concepts and definitions, and utilizes the LI-RADS v2014 algorithm to categorize representative observations depicted at magnetic resonance imaging in a case-based approach.
Keywords: ACR; HCC; LI-RADS.
© 2015 Wiley Periodicals, Inc.
Similar articles
-
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.J Hepatol. 2018 Mar;68(3):485-492. doi: 10.1016/j.jhep.2017.11.007. Epub 2017 Nov 11. J Hepatol. 2018. PMID: 29133247
-
Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm.J Hepatol. 2018 Apr;68(4):715-723. doi: 10.1016/j.jhep.2017.12.014. Epub 2017 Dec 21. J Hepatol. 2018. PMID: 29274407
-
Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1036-1044. doi: 10.1097/MEG.0000000000000916. Eur J Gastroenterol Hepatol. 2017. PMID: 28562394
-
Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.Gastroenterology. 2019 Mar;156(4):976-986. doi: 10.1053/j.gastro.2018.11.020. Epub 2018 Nov 13. Gastroenterology. 2019. PMID: 30445016
-
Understanding LI-RADS: a primer for practical use.Magn Reson Imaging Clin N Am. 2014 Aug;22(3):337-52. doi: 10.1016/j.mric.2014.04.007. Magn Reson Imaging Clin N Am. 2014. PMID: 25086933 Review.
Cited by
-
State of the art in abdominal MRI structured reporting: a review.Abdom Radiol (NY). 2021 Mar;46(3):1218-1228. doi: 10.1007/s00261-020-02744-8. Epub 2020 Sep 16. Abdom Radiol (NY). 2021. PMID: 32936418 Free PMC article. Review.
-
Can modified LI-RADS increase the sensitivity of LI-RADS v2018 for the diagnosis of 10-19 mm hepatocellular carcinoma on gadoxetic acid-enhanced MRI?Abdom Radiol (NY). 2022 Feb;47(2):596-607. doi: 10.1007/s00261-021-03339-7. Epub 2021 Nov 13. Abdom Radiol (NY). 2022. PMID: 34773467
-
Imaging of HCC-Current State of the Art.Diagnostics (Basel). 2015 Nov 27;5(4):513-45. doi: 10.3390/diagnostics5040513. Diagnostics (Basel). 2015. PMID: 26854169 Free PMC article. Review.
-
Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging.Eur Radiol. 2019 Jan;29(1):373-382. doi: 10.1007/s00330-018-5605-x. Epub 2018 Jun 28. Eur Radiol. 2019. PMID: 29955948
-
LI-RADS v2017 for liver nodules: how we read and report.Cancer Imaging. 2018 Apr 24;18(1):14. doi: 10.1186/s40644-018-0149-5. Cancer Imaging. 2018. PMID: 29690933 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
